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Background
Efficacy testing of immunotherapy in field studies is often
hampered by variation of airborne allergens. Standardized
allergen exposure in challenge chamber settings might
overcome aforementioned limitations. However, airborne
allergens such as house dust mite (HDM) or cat allergen
are not available as standardized source material with dis-
tinct particle size. Therefore, we developed a method for
universal allergen particle generation and conducted a
pilot study to clinically validate this challenge paradigm
for house dust mite.
Methods
House dust mite allergen extract (ALK lyophilised SQ503
Der p, ALK-Abello, Wedel, Germany) was diluted in an
aqueous solution of 10% lactose. The solution was spray-
dried at various liquid feed rates leading to allergen
aerosols with different pre-defined concentrations but a
constant mass mean aerodynamic particle diameter of
13.5 µm. Particle size is dependent on the solute (lactose)
concentration and can thereby be adjusted accordingly. In
a single-blind, five-way cross-over pilot study 18 subjects
with allergic rhinitis and sensitization to HDM were
allergen-exposed for 4 hours at either 250 SQE/m3, 500
SQE/m3, 1000 SQE/m3, or lactose alone (0 SQE/m3) seven
days apart. The dose of 500 SQE/m3 was repeated to
investigate reproducibility. Total nasal symptom score
(TNSS), anterior rhinomanometry, nasal secretions,
exhaled NO, FEV1, and adverse events were assessed prior
to and during the exposures.
Results
Allergen exposure was safe and significantly elicited
symptoms of AR compared to room air exposure with a
mean total nasal symptom score (TNSS) of 3.6±2.0
(mean±SD) at the highest allergen concentration. Lactose
alone did not change TNSS (0.7±0.6) compared to pre-
challenge level. Repeated exposure to 500 SQE/m3
induced a TNSS which was not different between the
two challenge sessions. Objective measures of nasal flow
and nasal secretions were in line with clinical symptoms.
Conclusions
We conclude that this universal allergen particle generation
is safe, specific, and reproducible and can therefore be
used for efficacy testing of immunotherapy.
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